Nausea on a GLP-1: what helps, and when to get help

How common it is, and how long it lasts

The best data come from the large weight-management trials of semaglutide and tirzepatide.

Semaglutide 2.4 mg (Wegovy). A pooled analysis of the STEP 1 to 3 trials, published in Diabetes, Obesity and Metabolism in 2022, followed 2,117 people on semaglutide and 1,262 on placebo for 68 weeks. Nausea affected 43.9% of those on semaglutide and 16.1% on placebo. Almost all stomach side effects, 98.1%, were mild to moderate, and they happened most often during or shortly after dose increases. Nausea was most common at about week 20, just after the dose reached 2.4 mg, and became less common after that. Individual bouts were short: a median of 8 days for nausea, 3 for diarrhoea and 2 for vomiting. Only 4.3% of people stopped treatment because of stomach side effects.

Tirzepatide (Mounjaro). Mounjaro's prescribing information pools the SURMOUNT-1 and SURMOUNT-2 trials. Nausea affected 24.6% of people on 5 mg, 29.0% on 10 mg and 28.0% on 15 mg, against 8.5% on placebo. Stomach side effects were mostly mild (61.0%) or moderate (34.4%), and nausea, vomiting and diarrhoea were more common while the dose was being increased and became less common over time.

One more finding from the semaglutide analysis is worth knowing. People lost about the same amount of weight whether or not they had stomach side effects, and less than one percentage point of the extra weight loss was explained by them. In that analysis, feeling sick was not a sign that the medicine was working harder.

Why it can come a day or two after the injection

GLP-1 medicines slow the stomach and act on the parts of the brain that control appetite and nausea, according to a 2025 joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society. The mechanism is not fully settled: a trial of semaglutide 2.4 mg found no clear sign of slower stomach emptying by week 20, measured indirectly.

There is a possible explanation for the timing within the week. The prescribing information says semaglutide reaches its highest level in the blood 1 to 3 days after a dose, and tirzepatide 8 to 72 hours after. The labels do not chart side effects day by day, so there is no official rule that day two or three will be the worst. But if yours are, that fits how these medicines are absorbed, and it is worth planning easier food for those days. (See what to eat on injection day.)

What helps

The NHS has a short, practical list for feeling sick, whatever the cause.

Things that may help:

• Eat smaller, more frequent meals.
• Take regular sips of a cold drink.
• Drink ginger or peppermint tea, or eat foods containing ginger, such as ginger biscuits.
• Get plenty of fresh air, and distract yourself.

Things to avoid:

• Hot, fried or greasy food, and strong-smelling food.
• Eating too quickly, or having a large drink with a meal.
• Lying down soon after eating.
• Clothes that are tight around your waist.

The joint advisory adds advice specific to GLP-1 medicines:

• Do not go long without eating. Nausea often comes in the morning or after a long gap. People can get caught in a cycle where feeling sick stops them eating, which makes the nausea worse. The advisory suggests breakfast, then a small meal every 3 to 4 hours, with enough to drink.
• Keep meals small. Vomiting is more likely after a large meal.
• Go easy on fatty and high-fibre food in the first few days of treatment.
• Ask about medicine. Anti-sickness medicines can help while you adjust to treatment and during dose increases. Your prescriber can decide whether one suits you.

When you can only manage a little, make it count. The advisory notes that smoothies, cottage cheese and soup are often more appealing than heavier food when appetite is low, and all three can carry protein. (See your first week on a GLP-1.)

Talk to your prescriber about the dose

You do not have to push through a dose increase that is making you ill. Wegovy's prescribing information says that if stomach symptoms are significant, the prescriber can consider delaying the next dose increase, or going back to the previous dose until symptoms improve. The joint advisory notes that in the clinical trials, people could stay on a dose for up to 8 weeks to let side effects settle. Do not change your dose yourself; ask. (See pausing a dose increase.)

Ginger: worth trying, but be honest about the evidence

Ginger is often sold as the answer to nausea. The evidence is more modest, and none of it involves GLP-1 medicines: a search of PubMed finds no trial of ginger for nausea caused by semaglutide, tirzepatide or liraglutide.

• In pregnancy, a 2014 meta-analysis of 12 trials in 1,278 women found ginger improved nausea compared with placebo, but did not significantly reduce vomiting. The authors described the evidence as low quality, and found no significant risk of side effects.
• In chemotherapy, a 2019 review of 18 articles found ginger at 1 g a day or less, taken for more than 3 days, was linked to a lower chance of acute vomiting. It found no link with the likelihood or severity of nausea.
• Overall, the US National Center for Complementary and Integrative Health says ginger may help nausea in pregnancy, that most studies have not shown it helps motion sickness, and that its value for chemotherapy nausea is uncertain.

So ginger tea or a ginger biscuit, as the NHS suggests, is a reasonable thing to try. Ginger supplements are different. The NCCIH notes they can cause stomach discomfort, heartburn, diarrhoea and mouth or throat irritation, and advises anyone taking medicines to check with a health professional first, because some herbs and medicines interact.

Keep fluids going

Nausea makes drinking hard, and sickness and diarrhoea both cost fluid. The prescribing information for semaglutide and tirzepatide warns that stomach side effects can lead to dehydration.

The NHS advice for dehydration: if you feel sick, start with small sips and gradually drink more, and avoid caffeinated drinks and alcohol. If you are being sick or have diarrhoea, a pharmacist can recommend oral rehydration solutions. Signs of dehydration include feeling thirsty, dark yellow and strong-smelling pee, peeing less often, feeling dizzy or light-headed and feeling tired. (See hydration on a GLP-1.)

The NHS also says it is best not to drink alcohol while using semaglutide or tirzepatide, because it can increase side effects such as feeling or being sick.

When it is reflux, not just nausea

Feeling sick can be part of acid reflux, and reflux is listed among tirzepatide's reported stomach side effects. The NHS says reflux symptoms are often worse after eating, when lying down and when bending over. Its advice is to eat smaller, more frequent meals, avoid food and drink that trigger your symptoms, and not eat within 3 or 4 hours before bed. A pharmacist can suggest medicines if it keeps happening.

Red flags: when it is not ordinary nausea

Most nausea on these medicines is unpleasant rather than dangerous. These are the exceptions.

Call NHS 111, or your prescriber, if:

• you have severe pain in your stomach or back that does not go away. The NHS lists this as a sign of an inflamed pancreas, a rare but serious side effect of both semaglutide and tirzepatide
• you keep being sick and cannot keep fluids down, or have been vomiting for more than 2 days
• you have signs of serious dehydration, such as feeling dizzy when you stand up that does not go away, or peeing less than normal
• you have pain in your tummy that lasts longer than 30 minutes, which the NHS says can be a sign of gallstones; tirzepatide lists gallstones among its serious side effects

Call 999 or go to A&E if:

• you have sudden, severe pain in your tummy, or pain that spreads from your tummy to your back while you are being sick
• your vomit contains blood or looks like ground coffee, or is green
• your skin or the whites of your eyes look yellow, or you have a very high temperature or feel hot, cold and shivery

If you take insulin or a sulfonylurea as well, watch for low blood sugar: the NHS lists sweating, shaking and feeling dizzy among the signs.

If there is any chance you are pregnant, take a test and tell your prescriber. Wegovy's prescribing information says semaglutide should be stopped if pregnancy occurs, and Mounjaro's says tirzepatide should not be used during pregnancy.

Outside the UK, call your local emergency number for anything in the 999 list.

Nausea and the menstrual cycle

If your nausea comes and goes on a pattern that does not match your injection day, it may be worth noting where you are in your cycle. The evidence here is thin. A small 1987 study of 7 women found that solid food left the stomach more slowly in the second half of the cycle, the luteal phase, and linked this to higher progesterone. It found no difference for liquids. No study has looked at whether GLP-1 nausea follows the cycle, so treat any pattern you notice as something to discuss with your prescriber, not as a known effect. (See the menstrual cycle and GLP-1 medicines.)

What to do with this

The calculator's "How this week has been" step asks about side effects, and some of them change your numbers. If you tick vomiting or diarrhoea, it suspends the calorie deficit, raises your fluid target and sets fibre a little lower, because you are losing fluid. If you tick nausea and your current dose started in the last 4 weeks, it switches you to protein first, so the protein goes in before your appetite runs out.

Work out this week's numbers

Sources

1. Wharton S, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab 2022. PubMed
2. Mounjaro KwikPen solution for injection in pre-filled pen: Summary of Product Characteristics. electronic medicines compendium. emc
3. Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen: Summary of Product Characteristics. electronic medicines compendium. emc
4. Ozempic 0.25 mg solution for injection in pre-filled pen: Summary of Product Characteristics. electronic medicines compendium. emc
5. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity Pillars 2025. PubMed
6. NHS. Feeling sick (nausea). nhs.uk
7. Viljoen E, et al. A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutr J 2014. PubMed
8. Crichton M, et al. Efficacy of Ginger (Zingiber officinale) in Ameliorating Chemotherapy-Induced Nausea and Vomiting and Chemotherapy-Related Outcomes: A Systematic Review Update and Meta-Analysis. J Acad Nutr Diet 2019. PubMed
9. Friedrichsen M, et al. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes Obes Metab 2021. PubMed
10. Gill RC, et al. Effect of the menstrual cycle on gastric emptying. Digestion 1987. PubMed
11. National Center for Complementary and Integrative Health. Ginger: Usefulness and Safety. nccih.nih.gov
12. NHS. Semaglutide. nhs.uk
13. NHS. Tirzepatide. nhs.uk
14. NHS. Diarrhoea and vomiting. nhs.uk
15. NHS. Dehydration. nhs.uk
16. NHS. Gallstones. nhs.uk
17. NHS. Heartburn and acid reflux. nhs.uk

Medical disclaimer: Articles in the foodose research library are educational, not medical advice. Severe, unusual or persistent side effects need a conversation with your prescriber. Call emergency services if any of the red flags above apply. See our full medical disclaimer.